Pillstats
Rx only · Suspension · Respiratory (Inhalation)

Budesonide Inhalation

Budesonide

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA07EA06
RxCUI (US)19831
US makers4 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.229$0.458$0.687$0.915Dec 2025Apr 2026Jul 2026
$0.693
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
4
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

14K28K42K56K2025 Q12025 Q22025 Q32025 Q42026 Q1
48K
Rx · 2026 Q1
5.2M
Units dispensed
+2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.